Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Leesa Bryant"'
Autor:
Timothy M. Doyle, Frank Porreca, Mahsa Mohammadebrahim Ghaffari, William L. Neumann, Leesa Bryant, Joshua W. Little, Zhoumou Chen, Daniela Salvemini
Publikováno v:
The Journal of Neuroscience. 32:10797-10808
Peroxynitrite (PN, ONOO−) is a potent oxidant and nitrating agent that contributes to pain through peripheral and spinal mechanisms, but its supraspinal role is unknown. We present evidence here that PN in the rostral ventromedial medulla (RVM) is
Autor:
Arthur J. Labovitz, Cade T. Lawrence, John E. Sagartz, Simil S. Gala, Daniel F. Hoft, Leesa Bryant, Christopher S. Eickhoff
Publikováno v:
Journal of Parasitology. 96:758-764
Chagas' disease, induced by Trypanosoma cruzi , is a common cause of infectious myocarditis. Recent clinical treatment trials and vaccine studies indicate that chagasic immunopathology is directed against the parasite and not self-antigens. Therefore
Autor:
Daniela N. Petrusca, Zhoumo Chen, Timothy M. Doyle, Irina Petrache, Daniela Salvemini, Emanuela Mazzon, Emanuela Masini, Emanuela Esposito, Salvatore Cuzzocrea, Leesa Bryant, M. Cristina Vinci
Publikováno v:
Neuroscience Letters. 463:49-53
Opiates, like morphine, are the most effective analgesics for treating acute and chronic severe pain, but their use is limited by the development of analgesic tolerance and hypersensitivity to innocuous and noxious stimuli. Because opioids are a main
Autor:
Joshua W. Little, Kali Janes, Ashley J. Snider, Irina Petrache, Daniela Salvemini, William L. Neumann, Lina M. Obeid, Leesa Bryant, Emanuela Esposito, Erhard Bieberich, Chao Li, Zhoumou Chen, Grant D. Nicol, Collin L. Chen, Krzysztof Kamocki, Salvatore Cuzzocrea, Timothy M. Doyle
Publikováno v:
The Journal of biological chemistry. 289(30)
The ceramide-sphingosine 1-phosphate (S1P) rheostat is important in regulating cell fate. Several chemotherapeutic agents, including paclitaxel (Taxol), involve pro-apoptotic ceramide in their anticancer effects. The ceramide-to-S1P pathway is also i
Autor:
Emanuela Esposito, Jan S. Ryerse, Kali Janes, Timothy M. Doyle, Daniela Salvemini, Salvatore Cuzzocrea, Gary J. Bennett, Leesa Bryant
Publikováno v:
Pain. 154(11)
Many of the widely used anticancer drugs induce dose-limiting peripheral neuropathies that undermine their therapeutic efficacy. Animal models of chemotherapy-induced painful peripheral neuropathy (CIPN) evoked by a variety of drug classes, including
Publikováno v:
The FASEB Journal. 27
Autor:
Timothy M. Doyle, Kali Janes, Amanda Finley, Daniela Salvemini, Kenneth A. Jacobson, Zhoumou Chen, Dilip K. Tosh, Leesa Bryant
Publikováno v:
The FASEB Journal. 27
The analgesic effectiveness of long-term opioid therapies is compromised by the development of antinociceptive tolerance linked to the overt production of peroxynitrite (ONOO(-), PN), the product of the interaction between superoxide (O2(-), SO) and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b024f32f73e8f0f5a2d114ed63d4f57
https://europepmc.org/articles/PMC4184413/
https://europepmc.org/articles/PMC4184413/
Autor:
Emanuela Esposito, William L. Neumann, Leesa Bryant, Timothy M. Doyle, Joshua W. Little, Smita Rausaria, Daniela Salvemini, Salvatore Cuzzocrea
Treatment of severe pain by morphine, the gold-standard opioid and a potent drug in our arsenal of analgesic medications, is limited by the eventual development of hyperalgesia and analgesic tolerance. We recently reported that systemic administratio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b23e5900407c960ae9d6867d37ec1eec
http://hdl.handle.net/11570/2541030
http://hdl.handle.net/11570/2541030
Autor:
Kenneth A. Jacobson, Dilip K. Tosh, Leesa Bryant, Kali Janes, Zhoumou Chen, Daniela Salvemini, Collin L. Chen, Timothy M. Doyle
Publikováno v:
FASEB journal : official publication of the Federation of American Societies for Experimental Biology. 26(5)
Clinical management of chronic neuropathic pain is limited by marginal effectiveness and unacceptable side effects of current drugs. We demonstrate A3 adenosine receptor (A3AR) agonism as a new target-based therapeutic strategy. The development of me